Intravenous Ketamine Produces Long-Term Pain Relief in a Patient with Fibromyalgia

Fibromyalgia is a common chronic widespread pain disorder for which there remains no gold standard treatment option. Here, we report a case of fibromyalgia in a female patient whose pain was refractory to treatment options such as a radiofrequency ablation, opioid analgesics and other pharmacotherapies. The patient commenced an experimental intravenous ketamine infusion therapy at the Florida Spine Institute (Clearwater, FL) and achieved complete remission from her chronic pain, an improved quality of life, and was able to reduce her reliance on multiple analgesic medications. Most interestingly, the patient has continued to report no pain in regular follow up visits for more than one year since her last ketamine infusion.